Delivering biologics via oral administration represents a growing market that is expected to exhibit 35% CAGR from 2023–2028.

Enveda’s pipeline is led by ENV-294, a first-in-class, oral small molecule being developed to treat atopic dermatitis and other inflammatory conditions by combining the advantages of blockbuster drugs ...

Kraig Biocraft Laboratories has developed transgenic silkworms to produce spider silk in commercial quantities.

Thaysen stepped in to lead Illumina through a tumultuous time, and now—as this GEN interview relates—he is carrying out his near- and long-term plans for the company.

Knowledge extraction: Through the application of AI and knowledge graphs, Wisecube were able to explore repurposed drugs for ...

SmartLabs’ new Custom Developed Solutions (CDS) platform provides specialized oversight and hands-on expertise in the design, ...